Information  X 
Enter a valid email address

Hikma Pharm PLC Ord Shs 10P (HIK)

Related News

17-May-2019 07:44 AM

Hikma Pharmaceuticals on track to meet expectations amid 'good' start to year

Hikma Pharmaceuticals said it was on track to meet full-year expectations following a 'good start' to the year, driven by recent product launches and good demand across all three businesses for its products. Its injectables business was perfo
21-Mar-2019 10:00 AM

Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC

Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target to 1800p (from 1950p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk..
19-Mar-2019 10:10 AM

Broker Forecast - Jefferies International issues a broker note on Hikma Pharmaceuticals PLC

Jefferies International today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target to 1960p (from 2000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
19-Mar-2019 10:00 AM

Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLC

Citigroup today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to buy (from neutral). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
14-Mar-2019 12:10 PM

Broker Forecast - HSBC issues a broker note on Hikma Pharmaceuticals PLC

HSBC today reaffirms its reduce investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1350p (from 1225p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
14-Mar-2019 09:10 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target to 1700p (from 1800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
13-Mar-2019 08:03 AM

Hikma Pharmaceuticals swings to profit led by ongoing growth in injectables business

Hikma Pharmaceuticals swung to a profit on Wednesday after it boosted injectables revenue, though it warned of lower sales in its generics business due to price cuts. For the 12 months to 31 December, the company reported a profit of $408m compared with
12-Mar-2019 09:00 AM

Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC

Peel Hunt today reaffirms its hold investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target to 1870p (from 2000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
27-Nov-2018 10:00 AM

Broker Forecast - Jefferies International issues a broker note on Hikma Pharmaceuticals PLC

Jefferies International today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to buy (from hold) and raised its price target to 2000p (from 1643p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesm
20-Nov-2018 02:30 PM

Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1900p (from 1050p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk..
12-Nov-2018 08:10 AM

Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC

Peel Hunt today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to hold (from add) and raised its price target to 2000p (from 1950p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.
09-Nov-2018 10:10 AM

Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC

Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1950p (from 1800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.u
08-Nov-2018 10:26 AM

Hikma Pharmaceuticals lifts revenue guidance following 'strong' Q3

Hikma Pharmaceuticals raised its full-year revenue guidance for both its injectables generic businesses after reporting 'strong' performance in the third quarter of the year. The company said it expected Injectables revenue to be in the range
06-Nov-2018 10:00 AM

Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC

Barclays Capital today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to equal weight (from underweight) and raised its price target to 1800p (from 1400p). Story provided by StockMarketWire.com Broker Forecasts data provided by ww
03-Oct-2018 08:50 AM

Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLC

Citigroup today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 2250p (from 2100p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
20-Aug-2018 09:00 AM

Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLC

Citigroup today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 2100p (from 1675p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
16-Aug-2018 08:30 AM

Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC

Peel Hunt today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to add (from hold) and raised its price target to 1950p (from 1160p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk.
15-Aug-2018 08:54 AM

Hikma Pharmaceuticals ups guidance as results top expectations

Hikma Pharmaceuticals raised guidance Wednesday for its injectables and generics businesses after reporting a jump in first-half profits. Injectables revenue is expected within a range of $775m to $825m and core operating margin for the full year to be
09-Aug-2018 09:20 AM

Broker Forecast - Numis issues a broker note on Hikma Pharmaceuticals PLC

Numis today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to hold (from add). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
03-Jul-2018 08:20 AM

Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLC

Citigroup today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1675p (from 1475p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
04-Jun-2018 09:55 AM

Hikma Pharmaceuticals appoints Henriette Nielsen as Chief Transformation Officer

Hikma Pharmaceuticals said Monday it had appointed Henriette Nielsen as Chief Transformation Officer. In this newly created role, Nielsen would be responsible for leading a number of initiatives across Hikma's global operations to improve operatio
18-May-2018 10:40 AM

Broker Forecast - Numis issues a broker note on Hikma Pharmaceuticals PLC

Numis today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to add (from buy) and raised its price target to 1560p (from 1300p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
18-May-2018 08:43 AM

Hikma Pharmaceuticals reiterates full-year guidance

Hikma Pharmaceuticals reiterated its full-year guidance on Friday after reporting that its injectables, generics and branded businesses benefited from new product launches in the first four months of the year. The company also said its efforts to reduce
01-May-2018 10:00 AM

Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLC

Citigroup today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1475p (from 1250p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
20-Apr-2018 09:28 AM

Hikma launches injection to reduce severity of cardiomyopathy

Hikma Pharmaceuticals said Friday its wholly-owned US subsidiary West-Ward Pharmaceuticals launched an injection to reduce the incidence and severity of cardiomyopathy, a chronic heart disease, in certain women with breast cancer. West-Ward launched Dex
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t